美國(guó)NOVABIOS 進(jìn)口違禁品快速檢測(cè)試劑盒

廣州健侖生物科技有限公司

廣州健侖生物長(zhǎng)期供應(yīng)各種違禁品檢測(cè)試紙、違禁品檢測(cè)卡、違禁品檢測(cè)試劑盒、藥篩試紙、藥篩試劑盒、嗎啡檢測(cè)試劑盒、巴比妥檢測(cè)試劑盒等。

如需訂購(gòu)或者了解請(qǐng)以下或

mob： 楊   ： 

主營(yíng)品牌：美國(guó)NovaBios、美國(guó)Cortez、國(guó)產(chǎn)創(chuàng)侖等等。

主要用途：篩查違禁品濫用殘留、麻醉藥殘留、興奮藥物殘留等等。

檢測(cè)范圍：嗎啡、KET、mamp、MDMA、BZO、THC、巴比妥、MTD、BAR、MDMA、AMP、BUP、PCP、TCA、OXY、MET等等。

產(chǎn)品特點(diǎn)：可以根據(jù)需求自主訂制多聯(lián)卡。多聯(lián)卡自由組合，從二聯(lián)到十五聯(lián)都可以訂制。

以下是部分產(chǎn)品違禁品檢測(cè)

美國(guó)NOVABIOS 進(jìn)口違禁品快速檢測(cè)試劑盒

檢測(cè)藥物殘留多聯(lián)卡快速檢測(cè)試劑盒

【儲(chǔ)存條件及有效期】

儲(chǔ)存條件：原包裝應(yīng)儲(chǔ)存于4～30℃避光干燥處，切忌冷凍。

有效期：24個(gè)月。

規(guī)格:40T/盒

試劑盒應(yīng)在鋁箔袋拆封后1小時(shí)內(nèi)盡快使用；建議在周圍溫度高于30℃或高濕度條件下，盡可能做到即開(kāi)即用。

本品采用競(jìng)爭(zhēng)抑制法和膠體金免疫層析技術(shù)，用于定性檢測(cè)人體尿液中尼古丁，適用于尼古丁藥物濫用的初步篩查。

The autumn of November 3, 2017 is the best time to hold group events and strengthen the cohesion of the company. Guangzhou Jianlun Biotechnology Co., Ltd. upholds the concepts and attitudes of solidarity, fraternity, mutual aid, dedication, collaboration, and innovation. To improve the physical fitness of employees and strengthen corporate culture, it actively participates in the Games organized by this Science Park.

 At 2 o'clock in the afternoon, in the sun, in the song, on the field, the first fun games of Panyu Innovation and Technology Park kicked off! With the high voice of the host, the crowds on the court lined up in neat rows. The team leader stood in the front of the team holding up the signs of each representative team. The participating athletes were eagerly arranged in the ranks and waiting for the start of the sports meeting. Then, the leader of the Science Park and the leader of the Guangzhou Mountaineering Association made a speech and wished the Games a success!

After the opening ceremony, under the leadership of the host, the athletes completed the warm-up exercise. The upcoming game is a rousing game. The company's first competition program is to test the coordination of the body and teamwork thunderbolt. As the whistle sounded, six colleagues carefully waved the balloons on the drums with a concerted pace and rhythm. The two colleagues were waiting for their help and were ready to pick up the flunging balloons. With nervousness and excitement, every colleague is working hard to complete the game. With the sound of the referee's ending, colleagues were relaxed, but due to lack of exercise, our performance on this project was not satisfactory. The company’s leader, Zhan Zhan, encouraged everyone at this time to cheer up morale and achieved better results in the next game.

At three o'clock in the afternoon, the colleagues of Jianlun Biology were engaged in a penalties game. Accompanied by cheers, I saw my colleagues kick one exciting goal after another and the score went up. In the end, Jianlun Bios achieved good results in the top five on this project. During the intermission, Zhan summoned everyone to a brief summary and encouraged everyone to continue their efforts to achieve better performance. Sure enough, in the following tortoise-bitch races and super-shooting sessions, colleagues performed better and better, demonstrating the positive appearance of Jianlun Biocorp. and the corporate culture of solidarity and cooperation.

At five o'clock in the afternoon, as the last athlete crossed the finish line, the game also came to a close. In the next award ceremony, the winning teams and athletes received commendation and prizes. The sports event was over, but the success and spirit gained through the games will continue to circulate, and it will become a shining landscape on the path of Guangzhou Jianlun Biosciences!

  努力，我們一直在路上，明天會(huì)更好！

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲(chóng)病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

更多產(chǎn)品說(shuō)明可通過(guò)下方的進(jìn)行了解

添加掃一掃二維碼：

【公司名稱】 廣州健侖生物科技有限公司

【 市場(chǎng)部 】       楊永漢
【】 
【騰訊  】
【公司地址】 廣州市清華科技園健新基地番禺石樓鎮(zhèn)健啟路63號(hào)二期2幢101-103室

ECM與腎臟纖維化各種原發(fā)性和/或繼發(fā)性致病原因所導(dǎo)致ECM合成與降解的動(dòng)態(tài)失 衡，促使大量ECM積聚而沉積于腎小球、腎間質(zhì)內(nèi)，導(dǎo)致腎臟各級(jí) 血管堵塞，混亂分隔形成腎臟組織形態(tài)學(xué)改變，zui終導(dǎo)致腎單位喪 失，腎功能衰竭，進(jìn)一步發(fā)展成為不可逆轉(zhuǎn)的腎小球硬化。硬化病 變過(guò)程如下：()腎小球硬化后，分泌合成大量的不易被降解的膠原，更促使了 腎臟細(xì)胞外基質(zhì)過(guò)度積聚。()系膜細(xì)胞病變抑制了腎臟纖溶酶的降解活性。()腎臟基質(zhì)金屬蛋白酶組織抑制因子與纖溶酶原激活抑制因子的 合成后，腎臟降解活性降低。()腎臟纖溶酶對(duì)腎臟細(xì)胞外基質(zhì)的降解能力降低后，導(dǎo)致腎小球 內(nèi)腎臟細(xì)胞外基質(zhì)合成異常增加，大量合成的腎臟細(xì)胞外基質(zhì)取代 了腎小球各功能細(xì)胞的空間，破壞了腎小球的組織結(jié)構(gòu)，損傷了腎 小球的功能，zui終導(dǎo)致腎小球硬化的形成。目前學(xué)者們*認(rèn)為惡性腫瘤的侵蝕、轉(zhuǎn)移是一個(gè)動(dòng)態(tài)的、連續(xù)的 過(guò)程。腫瘤細(xì)胞首先從原發(fā)部位脫落，侵入到細(xì)胞外基質(zhì) (extrcellulr m-tric,ECM).
The imbalance of ECM synthesis and degradation caused by various primary and/or secondary pathogenesis of ECM and renal fibrosis contributes to the accumulation of a large number of ECM deposits in glomeruli and renal interstitium, leading to blood vessels at various levels of the kidneys. Blockage and confusion separate formation of renal tissue morphological changes, eventually leading to loss of nephrons, renal failure, and further development of irreversible glomerulosclerosis. The process of sclerosis is as follows: () After glomerulosclerosis, secrete and synthesize a large amount of collagen that is not easily degraded, which further promotes excessive accumulation of extracellular matrix in the kidney. () Mesangial cytopathy inhibits the degradation activity of renal plasmin. () After the synthesis of renal matrix metalloproteinase tissue inhibitor and plasminogen activation inhibitor, the renal degrading activity is reduced. () Renal plasmin degradation of the extracellular matrix of the kidneys results in an abnormal increase in the extracellular matrix synthesis of the kidneys in the glomerulus. The massive synthesis of the renal extracellular matrix replaces the space of the glomerular functional cells, destroying The glomerular tissue structure damages the function of the glomerulus and eventually leads to the formation of glomerulosclerosis. Current scholars agree that the erosion and metastasis of malignant tumors is a dynamic and continuous process. Tumor cells first detach from the primary site and invade the extracellular matrix (ECM)